Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2019

Feb 7, 2019

29745_dirs_2019-02-06_68a0e6ad-7c54-4306-84bb-1865cb16c60f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2019-02-01

Reporting Person: O'Neill Myles (SVP & Pres., Mfg. Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-02-01 Common Stock M 3221 Acquired 54175 Indirect
2019-02-01 Common Stock F 1491 $119.86 Disposed 52684 Indirect
2019-02-04 Common Stock A 4635 $120.17 Acquired 57319 Indirect
2019-02-04 Common Stock A 8592 $120.17 Acquired 40645 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-02-01 Restricted Stock Unit $ M 3221 Disposed 2019-02-01 Common Stock (3221.0) Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1180 Indirect
Common Stock 1090 Indirect

Footnotes

F1: Reporting person disclaims beneficial ownership of these shares.

F2: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.